Biopharma Leader James Hoyes Joins RxC International as Executive Partner

MORRISTOWN, N.J.--(BUSINESS WIRE)--RxC International, a premier life sciences management consulting firm, announced today that James Hoyes has joined the firm as an executive partner. Hoyes had been working with RxC International as a senior advisor since 2014. He has a long track record of creating strategies and driving exceptional performance in the life sciences sector.

In addition to providing advisory services to RxC International clients, Hoyes will focus on corporate development initiatives in the life sciences sector and the implementation of key strategic initiatives designed to scale up the firm’s global operations. He will be based in Cambridge, Massachusetts.

RxC International Managing Partner Subbarao Jayanthi said, “Jim’s addition represents another milestone in the expansion of our business. He has an outstanding track record as a leader in the life sciences sector, and his deep strategic and executive leadership expertise will be invaluable to our clients.”

Prior to joining RxC International, Hoyes served as President of EMD Serono, leading the company in consistent double-digit revenue gains. Prior to EMD Serono, Hoyes held leadership positions with several leading biopharma companies, including chief commercial officer at Serono, vice president of marketing at Elan, vice president of managed markets at Sanofi, and senior director of cardiovascular and strategic marketing at Sanofi-Synthélabo.

RxC International Executive Partner James Hoyes said, “Today, both the opportunities and challenges for biopharma companies are many – the growing complexity and increasing interdependencies require the right perspective and a steady hand. Actually, realizing the value of an unmet need is not always easy. RxC International helps clients navigate the competitive landscape in order to maximize value and build a sustainable position in a given therapeutic area. The business model of RxC International – working closely as partners with clients and developing a compelling strategy and a clear plan to execute – resonates well with our growing list of clients. I am pleased and excited to join the RxC International team to focus on value and growth creation for clients.”

Hoyes holds a bachelor of science in biology from the Pennsylvania State University. He has served on the boards of the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO). He currently serves as a board member of MassBIO.

About RxC International

RxC International is a premier life sciences management consulting firm. RxC collaborates with clients to identify and develop growth opportunities. The firm leverages consulting partners and advisers to combine strategic and operational expertise to bring multiple perspectives to every engagement. The firm has deep expertise in corporate strategy, new product planning and commercial excellence. Clients include leading pharmaceutical, biotechnology, and medical technology companies around the world. The firm also supports private equity and venture capital firms on strategic transactions. The firm’s corporate headquarters is located in Morristown, New Jersey, and it has offices in Massachusetts and California. Additional information about RxC International can be found at


RxC International
Subbarao Jayanthi, 855-792-7920